Ullem Scott B. 4

What Happened

• Scott B. Ullem, Chief Financial Officer of Edwards Lifesciences (EW), exercised 13,000 stock options on May 5, 2026 at an exercise price of $59.26, for a cash cost of about $770,337. To cover taxes and/or the exercise price, a total of 11,751 shares were withheld/disposed (620 shares on May 3 and 11,131 shares on May 5) at market prices (~$52,068 and ~$922,871 respectively). The filing shows the option conversion entry plus the withholding entries; net shares retained from this transaction are approximately 1,249 shares (13,000 acquired minus 11,751 withheld).

Key Details

• Transaction types/codes: M = option exercise (13,000 shares @ $59.26, $770,337); F = payment of exercise price/tax withholding (620 shares @ $83.98 = $52,068; 11,131 shares @ $82.91 = $922,871).
• Transaction dates: May 3, 2026 (620 shares withheld); May 5, 2026 (option exercise and 11,131 shares withheld).
• Net shares retained from the exercise: ~1,249 shares.
• Shares owned after transaction: not disclosed in this Form 4.
• Filing timeliness: Form filed May 5, 2026; no late filing flag indicated in the report.

Context

• This was an option exercise with shares withheld to cover taxes/exercise costs (a common cashless-type settlement), not an open-market sell; withheld shares are routine and do not necessarily signal a change in sentiment.
• The beneficial change reflects conversion of derivatives (options) into common shares; purchases via exercise can increase insider exposure, but the large withholding means only a small net increase in shares held.